Science Explorer Back to mapMap
Discussion
Researcher · The Heart Research Institute · Australia

Keith K. Stanley

Keith K. Stanley publishes mostly in Molecular Biology, Immunology and Cell Biology, on topics such as Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research and Complement system in diseases.

OpenAlex
World rank
#570,804
of 7,710,434 ranked researchers
Rank in Australia
#19,602
of 140,210
Works
122
Citations
8.7k
Citations per work
71.4
h-index
46
i10-index 87Top 4.8% in Molecular Biology
Keith K. Stanley

What does Keith K. Stanley research?

Keith K. Stanley's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (14%), Immunology and Microbiology (9%).

Life Sciences: 56 works · 45.7% of their workBiochemistry, Genetics and Molecular Biology: 45 works · 36.6% of their workMolecular Biology: 36 works · 29.2% of their workCell Biology: 9 works · 7.4% of their workImmunology and Microbiology: 11 works · 9.1% of their workImmunology: 11 works · 9.1% of their workEverything else: 49 works · 40.4% of their workHealth Sciences: 17 works · 13.9% of their workMedicine: 17 works · 13.9% of their workRadiology, Nuclear Medicine and Imaging: 8 works · 6.5% of their workInfectious Diseases: 5 works · 4.0% of their workSurgery: 4 works · 3.4% of their workTHEIR WORKKeith K. Stanley122works
Life Sciences46%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4536.6%
    2. Immunology and Microbiology119.1%
  2. Everything else4940.4%
    1. Medicine1713.9%
  1. 1Molecular Biology29% of their works
  2. 2Immunology9% of their works
  3. 3Cell Biology7% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Infectious Diseases4% of their works
  6. 6Surgery3% of their works

Research topics

Which keywords describe Keith K. Stanley's research?

The keywords of their largest research topics: Glycosylation, Cancer, Fc Receptors, Glycans, Therapeutic Antibodies, Complement, Immune and Endocytosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Glycosylation442 topics
  2. Cancer221 topic
  3. Fc Receptors221 topic
  4. Glycans221 topic
  5. Therapeutic Antibodies221 topic
  6. Complement191 topic
  7. Immune191 topic
  8. Endocytosis172 topics
  9. Lipid Rafts132 topics
  10. Ribosome131 topic
  11. Translation131 topic
  12. Membrane Fusion101 topic
  13. Rab Proteins101 topic
  14. Adenosine Receptors81 topic
  15. Purinergic Signalling81 topic
  16. Caveolae71 topic
  17. Caveolin71 topic
  18. Cholesterol61 topic
  19. Membrane Lipids61 topic

Where does Keith K. Stanley work?

Keith K. Stanley's main affiliation in the publication record is The Heart Research Institute, Australia.

How many publications and citations does Keith K. Stanley have?

OpenAlex counts 122 works and 8,710 citations for Keith K. Stanley, an h-index of 46, ranking #570,804 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Keith K. Stanley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.